Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meulbroek

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Nutrition|November 1, 1994
Enteral formula composition does not affect response to lethal infectious challenge in miceJ D Alder, J Meulbroek, K Jarvis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infectionsJ Alder, J Clement, J Meulbroek, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strainsA Oleksijew, J Meulbroek, P Ewing, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Efficacies of ABT-773, a new ketolide, against experimental bacterial infectionsM J Mitten, J Meulbroek, M Nukkala, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Nutrition|November 1, 1994
Enteral formula composition does not affect response to lethal infectious challenge in miceJ D Alder, J Meulbroek, K Jarvis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infectionsJ Alder, J Clement, J Meulbroek, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strainsA Oleksijew, J Meulbroek, P Ewing, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Efficacies of ABT-773, a new ketolide, against experimental bacterial infectionsM J Mitten, J Meulbroek, M Nukkala, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agentsQ Li, D T Chu, A Claiborne, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Pageof 1